577 related articles for article (PubMed ID: 22735796)
1. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.
Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F
Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a new HIV-1 DNA construct in a BALB/c mouse model.
Mahdavi M; Ebtekar M; Mahboudi F; Khorram Khorshid H; Rahbarizadeh F; Azadmanesh K; Darabi H; Pourasgari F; Hassan ZM
Iran J Immunol; 2009 Dec; 6(4):163-73. PubMed ID: 20054104
[TBL] [Abstract][Full Text] [Related]
3. Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses.
Velashjerdi Farahani S; Reza Aghasadeghi M; Memarnejadian A; Faezi S; Shahosseini Z; Mahdavi M
Pathog Glob Health; 2016 Mar; 110(2):39-47. PubMed ID: 26403975
[TBL] [Abstract][Full Text] [Related]
4. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24.
Suzue K; Young RA
J Immunol; 1996 Jan; 156(2):873-9. PubMed ID: 8543845
[TBL] [Abstract][Full Text] [Related]
6. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens.
Okada E; Sasaki S; Ishii N; Aoki I; Yasuda T; Nishioka K; Fukushima J; Miyazaki J; Wahren B; Okuda K
J Immunol; 1997 Oct; 159(7):3638-47. PubMed ID: 9317164
[TBL] [Abstract][Full Text] [Related]
7. ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses.
Mahdavi M; Ebtekar M; Khorram Khorshid HR; Azadmanesh K; Hartoonian C; Hassan ZM
Immunol Lett; 2011 Oct; 140(1-2):14-20. PubMed ID: 21679728
[TBL] [Abstract][Full Text] [Related]
8. Improvement in T helper 1-related immune responses in BALB/c mice immunized with an HIV-1 gag plasmid combined with a chimeric plasmid encoding interleukin-18 and flagellin.
Chen YL; Chen YS; Hung YC; Liu PJ; Tasi HY; Ni WF; Hseuh PT; Lin HH
Microbiol Immunol; 2015 Aug; 59(8):483-94. PubMed ID: 26094825
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development.
Franco D; Li W; Qing F; Stoyanov CT; Moran T; Rice CM; Ho DD
Vaccine; 2010 Aug; 28(35):5676-85. PubMed ID: 20600494
[TBL] [Abstract][Full Text] [Related]
10. [Immunological efficiency induced by HIV-1 p24 DNA combined with P24 protein].
Wang Q; Chen Y; Gao S; Jiang W; Song L; Huang W
Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):773-80. PubMed ID: 21845844
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of immune responses to an HIV env DNA vaccine by a C-terminal segment of listeriolysin O.
Bu Z; Ye L; Skeen MJ; Ziegler HK; Compans RW; Yang C
AIDS Res Hum Retroviruses; 2003 May; 19(5):409-20. PubMed ID: 12803999
[TBL] [Abstract][Full Text] [Related]
13. Mucosal Priming with a Recombinant Influenza A Virus-Vectored Vaccine Elicits T-Cell and Antibody Responses to HIV-1 in Mice.
Wang J; Shu T; Deng W; Zheng Y; Liao M; Ye X; Han L; He P; Zheng X; Li T; Feng Y; Hu F; Li P; Sun C; Chen L; Li F; Feng L
J Virol; 2021 May; 95(12):. PubMed ID: 33789991
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
Jiang W; Ren L; Jin N
J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
[TBL] [Abstract][Full Text] [Related]
15. Induction of mucosal HIV-specific B and T cell responses after oral immunization with live coxsackievirus B4 recombinants.
Gu R; Stagnar C; Zaichenko L; Ramsingh AI
Vaccine; 2012 May; 30(24):3666-74. PubMed ID: 22464964
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Gag p24-Nef fusion peptide induces cellular and humoral immune response in a mouse model.
Mahdavi M; Ebtekar M; Azadmanesh K; Khorramkhorshid HR; Rahbarizadeh F; Yazdi MH; Zabihollahi R; Abolhassani M; Hassan ZM
Acta Virol; 2010; 54(2):131-6. PubMed ID: 20545443
[TBL] [Abstract][Full Text] [Related]
17. Characterization of immune responses induced by combined clade-A HIV-1 recombinant adenovectors in mice.
Bayanolhagh S; Alinezhad M; Kamali K; Foroughi M; Khorram Khorshid HR; Mohraz M; Mahboudi F; Pourfathollah AA
Iran J Immunol; 2010 Sep; 7(3):162-76. PubMed ID: 20876987
[TBL] [Abstract][Full Text] [Related]
18. Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein.
Ye L; Sun Y; Lin J; Bu Z; Wu Q; Jiang S; Steinhauer DA; Compans RW; Yang C
Virology; 2006 Aug; 352(1):74-85. PubMed ID: 16725170
[TBL] [Abstract][Full Text] [Related]
19. An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization.
Lemiale F; Asefa B; Ye D; Chen C; Korokhov N; Humeau L
Vaccine; 2010 Feb; 28(8):1952-61. PubMed ID: 20188251
[TBL] [Abstract][Full Text] [Related]
20. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
Gómez CE; Abaitua F; Rodríguez D; Esteban M
Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
